Direxion Daily S&P Biotech Bear 3X Shares (1BM3)

Overview

The fund, characterized by its specialized investment approach, targets the biotechnology sector, emphasizing the use of financial derivatives to achieve its objectives. Primarily leveraging instruments like swap agreements, futures contracts, or short positions, the fund aims to provide investors with 3X daily inverse exposure to its benchmark index. This indexing strategy focuses on the performance of the biotechnology sub-industry, as defined by the Global Industry Classification Standard (GICS). It's important to note that this fund adopts a non-diversified investment strategy, concentrating its assets in a way that significantly differs from more traditional investment funds.

Products and Services

The fund's offerings can be primarily categorized into financial instruments designed to inversely mirror the performance of the biotechnology sector. These products and services include:

• Swap Agreements: These are contracts between two parties to exchange sequences of cash flows for a set period. In the context of this fund, swap agreements are utilized to create the inverse exposure to the biotechnology index, effectively allowing investors to bet against the market performance of this sector.
• Futures Contracts: Futures contracts are standardized legal agreements to buy or sell something (in this case, indices or assets related to the biotechnology industry) at a predetermined price at a specified time in the future. For this fund, futures are instrumental in achieving 3X daily inverse leverage, amplifying the potential returns (or losses) from movements in the biotechnology index.
• Short Positions: Taking a short position involves selling securities that one does not own, with the expectation that their price will fall. The fund uses short positions as another method to provide inverse exposure to the biotechnology index, allowing investors to profit from declines in the sector's market value.